Dr. Nakakura - Neuroendocrine Tumors of Unknown Primary: Is the Primary Site Really Not Known?
- New Class of Drug Appears to Extend Survival in Patients With Triple-Refractory Multiple Myeloma
July 30, 2020 | Source: CancerTherapyAdvisor.com
- Bay Area Cancer Patient Soldiers on Despite COVID-19 Challenges
July 30, 2020 | Source: NBCBayArea.com
- Study reveals risk factors for upgrading in active surveillance for prostate cancer
July 27, 2020 | Source: UrologyTimes.com